Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
ACS Applied Materials & Interfaces|December 5, 2015
Dip-in Indicators for Visual Differentiation of Fuel Mixtures Based on Wettability of Fluoroalkylchlorosilane-Coated Inverse Opal FilmsAbootaleb Sedighi, Shuang Qiu, Michael C K Wong, et al.
Methods in Molecular Biology (Clifton, N.J.)|October 18, 2022
Evaluation of Small-Molecule HDAC Inhibitors Through In Vitro and In Cellulo ApproachesNabanita Nawar, Harsimran Kaur Garcha, Abootaleb Sedighi, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|August 1, 2017
Inorganic Nanoparticles as Donors in Resonance Energy Transfer for Solid-Phase Bioassays and BiosensorsYi Han, M Omair Noor, Abootaleb Sedighi, et al.
Biochemistry|October 19, 2023
High-Affinity Fluorogenic Substrate for Tissue Transglutaminase Reveals Enzymatic HysteresisEric W J Gates, Adrien Prince-Hallée, Yasaman Heidari, et al.
Journal of Medicinal Chemistry|December 7, 2023
Discovery of YSR734: A Covalent HDAC Inhibitor with Cellular Activity in Acute Myeloid Leukemia and Duchenne Muscular DystrophyYasir S Raouf, Abootaleb Sedighi, Mulu Geletu, et al.
Journal of Medicinal Chemistry|March 10, 2025
Monoselective Histone Deacetylase 6 PROTAC Degrader Shows <i>In Vivo</i> TractabilityHarsimran K Garcha, Olasunkanmi O Olaoye, Abootaleb Sedighi, et al.
Chemmedchem|August 19, 2022
Phenotypic Screening of Histone Deacetylase (HDAC) Inhibitors against Schistosoma mansoniMuhammad Murtaza Hassan, Abootaleb Sedighi, Olasunkanmi O Olaoye, et al.
ACS Medicinal Chemistry Letters|January 16, 2020
Class I/IIb-Selective HDAC Inhibitor Exhibits Oral Bioavailability and Therapeutic Efficacy in Acute Myeloid LeukemiaAndrew E Shouksmith, Justyna M Gawel, Nabanita Nawar, et al.
Journal of Medicinal Chemistry|July 17, 2020
Characterization of Conformationally Constrained Benzanilide Scaffolds for Potent and Selective HDAC8 TargetingMuhammad Murtaza Hassan, Johan Israelian, Nabanita Nawar, et al.
European Journal of Medicinal Chemistry|July 3, 2020
PTG-0861: A novel HDAC6-selective inhibitor as a therapeutic strategy in acute myeloid leukaemiaJustyna M Gawel, Andrew E Shouksmith, Yasir S Raouf, et al.
Pageof 3